CCL

CCL Products (India) vs Peers

₹1,055.00+0.01%
Market cap
₹14,052 crore
P/E
32.5
P/B
5.99
ROE
18.0%
Dividend yield
0.28%

CCL Products (India) ranks 2nd by market capitalisation among 7 Tea & Coffee companies tracked by ATS. Its largest peers are TATA CONSUMER PRODUCTS, Andrew Yule & Company and Gillanders Arbuthnot & Company. Its P/E of 32.5 compares with a peer median of 31.0.

CCL Products (India) vs Tea & Coffee peers

Sorted by market capitalisation.

CCL Products (India) and peers compared on size, valuation and returns
CompanyClose (₹)1DMarket cap (₹ cr)P/EP/BROE1Y return
TATA CONSUMER PRODUCTS967.85-0.84%95,77558.64.407.4%+12.5%
CCL Products (India)1,055.00+0.01%14,05232.55.9918.0%+22.0%
Andrew Yule & Company24.73-0.88%1,20922.53.72-5.8%+12.5%
Gillanders Arbuthnot & Company109.38-2.14%23313.40.913.8%+12.5%
Dhunseri Tea & Industries153.00-0.65%16122.50.30-0.5%+12.5%
Ganges Securities113.96-1.61%11439.60.210.4%+12.5%
B & A351.10-0.20%109142.60.79-2.8%+12.5%

Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.

CCL Products (India) peer comparison — frequently asked questions

Who are CCL Products (India)'s competitors?

CCL Products (India)'s listed peers in Tea & Coffee include TATA CONSUMER PRODUCTS, Andrew Yule & Company, Gillanders Arbuthnot & Company, Dhunseri Tea & Industries, Ganges Securities and B & A, ranked here by market capitalisation.

How does CCL Products (India)'s P/E compare with its peers?

CCL Products (India) trades at a P/E of 32.5, against a median of 31.0 across the 6 Tea & Coffee peers shown.

Which is the largest company among CCL Products (India)'s peers?

By market capitalisation, the largest company in the group is TATA CONSUMER PRODUCTS at ₹95,775 crore, against ₹14,052 crore for CCL Products (India).

Same Data For Peers

Trade CCL Products (India) With ATS

Track CCL live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.